Cargando…
Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis
Autores principales: | Van Ackerbroeck, Sofie, Rutsaert, Lynn, Roelant, Ella, Dillen, Kathleen, Wauters, Joost, Van Regenmortel, Niels |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374123/ https://www.ncbi.nlm.nih.gov/pubmed/34412686 http://dx.doi.org/10.1186/s13054-021-03728-w |
Ejemplares similares
-
Invasive Aspergillus Tracheobronchitis Emerging as a Highly Lethal Complication of Severe Influenza
por: van de Veerdonk, Frank L., et al.
Publicado: (2020) -
Pseudomembranous Aspergillus Tracheobronchitis: Case Report of a Rare Manifestation of Airway Invasive Aspergillosis
Publicado: (2022) -
Novel inhaled antifungal for pseudomembranous Aspergillus tracheobronchitis complicating connective tissue disease
por: Singh, Shivani, et al.
Publicado: (2023) -
COVID-19-associated invasive pulmonary aspergillosis
por: Rutsaert, Lynn, et al.
Publicado: (2020) -
Inhaled Amphotericin B as Aspergillosis Prophylaxis in Hematologic
Disease: An Update
por: Duckwall, Madison J, et al.
Publicado: (2019)